TickerFacts.

Benitec Biopharma Inc. (BNTC): Operating Income

Annual figures by period end, from SEC filings.

-$51.19M
Year ended 2026-06-30
$2.58M2019-06-30: $2.58M2020-06-30: -$8.28M2021-06-30: -$13.60M2022-06-30: -$17.85M2023-06-30: -$19.08M2024-06-30: -$22.49M2025-06-30: -$41.77M2026-06-30: -$51.19M-$51.19M
2019-06-30 Operating Income (USD) 2026-06-30
Period endedOperating IncomeChange YoYSource filing
2026-06-30-$51.19Mn/m2026-09-14, From 2025-07-01
2025-06-30-$41.77Mn/m2026-09-14, From 2024-07-01
2024-06-30-$22.49Mn/m2026-03-20, From 2023-07-01
2023-06-30-$19.08Mn/m2024-09-26, From 2022-07-01
2022-06-30-$17.85Mn/m2023-09-21, From 2021-07-01
2021-06-30-$13.60Mn/m2022-09-02, From 2020-07-01
2020-06-30-$8.28Mn/m2021-09-20, From 2019-07-01
2019-06-30$2.58Mn/a2020-09-23, From 2018-07-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Benitec Biopharma Inc. (BNTC)2026-06-30-$51.19Mn/m
Alto Neuroscience, Inc. (ANRO)2025-12-31-$66.36Mn/m
Lexicon Pharmaceuticals, Inc. (LXRX)2025-12-31-$48.91Mn/m
Fortress Biotech, Inc. (FBIO)2025-12-31-$70.22Mn/m
PepGen Inc. (PEPG)2025-12-31-$93.61Mn/m
Adicet Bio, Inc. (ACET)2025-12-31-$122.11Mn/m
Trevi Therapeutics, Inc. (TRVI)2025-12-31-$49.33Mn/m
Gossamer Bio, Inc. (GOSS)2025-12-31-$170.73Mn/m
Foghorn Therapeutics Inc. (FHTX)2025-12-31-$86.39Mn/m

Compare BNTC, ANRO, LXRX, FBIO side by side · Screen every company in Pharmaceutical Preparations ↗